1. Giving AXL the axe: targeting AXL in human malignancy
    Carl M Gay et al, 2017, Br J Cancer CrossRef
  2. Id-1 promotes osteosarcoma cell growth and inhibits cell apoptosis via PI3K/AKT signaling pathway
    Liang Hao et al, 2016, Biochemical and Biophysical Research Communications CrossRef
  3. Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies
    Alessandro Allegra et al, 2017, Cancer Investigation CrossRef
  4. Mistletoe ( Viscum album ) extract targets Axl to suppress cell proliferation and overcome cisplatin- and erlotinib-resistance in non-small cell lung cancer cells
    Soyoung Kim et al, 2017, Phytomedicine CrossRef
  5. null
    Devivasha Bordoloi et al, 2018 CrossRef
  6. Cell softening in malignant progression of human lung cancer cells by activation of receptor tyrosine kinase AXL
    Keisuke Iida et al, 2017, Sci Rep CrossRef
  7. AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications
    Chenjing Zhu et al, 2019, Mol Cancer CrossRef
  8. MicroRNA-509-3p inhibits cellular migration, invasion, and proliferation, and sensitizes osteosarcoma to cisplatin
    Sagar L. Patil et al, 2019, Sci Rep CrossRef
  9. Antibody–drug conjugates for lung cancer in the era of personalized oncology
    Biagio Ricciuti et al, 2019, Seminars in Cancer Biology CrossRef
  10. Therapeutic potentials of curcumin in the treatment of non‐small‐cell lung carcinoma
    Mahsa Salehi et al, 2020, Phytotherapy Research CrossRef
  11. Versatile role of curcumin and its derivatives in lung cancer therapy
    Milad Ashrafizadeh et al, 2020, J Cell Physiol CrossRef
  12. Curcumin in cancer therapy: A novel adjunct for combination chemotherapy with paclitaxel and alleviation of its adverse effects
    Milad Ashrafizadeh et al, 2020, Life Sciences CrossRef
  13. Curcumin Nanoemulsion: Evaluation of Stability and Anti-Cancer Activity In Vitro
    Thanh Binh Nguyen et al, 2020, JNanoR CrossRef
  14. Nanoscale Formulations: Incorporating Curcumin into Combination Strategies for the Treatment of Lung Cancer
    Quhui Wu et al, 2021, DDDT CrossRef
  15. Antibody Drug Conjugates in Lung Cancer: state of the current therapeutic landscape and future developments
    Joshua E. Reuss et al, 2021, Clinical Lung Cancer CrossRef
  16. Recent Advances in Elucidating Paclitaxel Resistance Mechanisms in Non-small Cell Lung Cancer and Strategies to Overcome Drug Resistance.
    Hongmei Cui et al, 2020, Curr Med Chem CrossRef
  17. Targeting MERTK and AXL in EGFR Mutant Non-Small Cell Lung Cancer
    Dan Yan et al, 2021, Cancers CrossRef
  18. Exploring the Gamut of Receptor Tyrosine Kinases for Their Promise in the Management of Non-Alcoholic Fatty Liver Disease
    Sayali Bhave et al, 2021, Biomedicines CrossRef
  19. Berberine-loaded liquid crystalline nanoparticles inhibit non-small cell lung cancer proliferation and migration in vitro
    Keshav R. Paudel et al, 2022, Environ Sci Pollut Res CrossRef
  20. GTP-binding protein Di-RAS3 diminishes the migration and invasion of non-small cell lung cancer by inhibiting the RAS/extracellular-regulated kinase pathway
    Peng Kuang et al, 2022, Bioengineered CrossRef
  21. Integrated Proteomics-Based Physical and Functional Mapping of AXL Kinase Signaling Pathways and Inhibitors Define Its Role in Cell Migration.
    Anurima Majumder et al, 2022, Mol Cancer Res CrossRef
  22. Psoralidin protects against cerebral hypoxia/reoxygenation injury: Role of GAS6 /Axl signaling
    Wangrui Lei et al, 2022, Phytotherapy Research CrossRef
  23. Reconnoitering the Therapeutic Role of Curcumin in Disease Prevention and Treatment: Lessons Learnt and Future Directions
    Bala Mohan Sivani et al, 2022, Metabolites CrossRef
  24. Curcumin and Its Analogs in Non-Small Cell Lung Cancer Treatment: Challenges and Expectations
    Chunyin Tang et al, 2022, Biomolecules CrossRef
  25. Processing and Physicochemical Properties of Magnetite Nanoparticles Coated with Curcuma longa L. Extract
    Margarita L. Alvarado-Noguez et al, 2023, Materials CrossRef
  26. Zerumbone-incorporated liquid crystalline nanoparticles inhibit proliferation and migration of non-small-cell lung cancer in vitro
    Bikash Manandhar et al, 2023, Naunyn-Schmiedeberg's Arch Pharmacol CrossRef
  27. Curcuminoid Nanovesicles as Advanced Therapeutics
    Hanna S. Abbo et al, 2023, ChemBioEng Reviews CrossRef
  28. Ethyl pyruvate attenuates cerebral hypoxia/reoxygenation injury in neuroblastoma cells: Role of GAS6/Axl signaling
    Ying Chen et al, 2023, Heliyon CrossRef
  29. Discovery of novel and potent dual-targeting AXL/HDAC2 inhibitors for colorectal cancer treatment via structure-based pharmacophore modelling, virtual screening, and molecular docking, molecular dynamics simulation studies, and biological evaluation
    Xiao Qiao et al, 2024, Journal of Enzyme Inhibition and Medicinal Chemistry CrossRef
  30. Curcumin in Cancer and Inflammation: An In-Depth Exploration of Molecular Interactions, Therapeutic Potentials, and the Role in Disease Management
    Dong-Oh Moon, 2024, IJMS CrossRef